The value of repeated measurement of the Brain Natiuretic Peptide for the diagnosis of unstable angina;Intérêt des dosages répétés du brain natriuretic peptide pour le diagnostic d'angor instable

Archives des Maladies du Coeur et des Vaisseaux

Volumn 96, Issue 4, 2003, Pages 305-310

  Leroy, G ^b   Uzan, L ^b   Bugugnani, M J ^b   Boukhsibi, F ^b   Phung, H ^b   Meddane, M ^b   Weingrod, M ^b   Stoltz, J P ^b   Halphen, C ^b   Haiat, R ^a  

^a Serv cardiologie St Germainen Laye   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; TROPONIN;

ACUTE DISEASE; ADULT; AGED; ANALYTIC METHOD; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ECG ABNORMALITY; ELECTROCARDIOGRAM; FEMALE; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE ISCHEMIA; HEART SCINTISCANNING; HUMAN; KINETICS; MALE; PEPTIDE ANALYSIS; PROTEIN BLOOD LEVEL; RELIABILITY; ST SEGMENT ELEVATION; THORAX PAIN; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; BIOLOGICAL MARKERS; CHEST PAIN; CORONARY DISEASE; FEMALE; HUMANS; KINETICS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; TIME FACTORS;

EID: 0038327856     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Myocardial infarction redefined - A consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000; 21: 1502-13 and J Am Coll Cardiol 2000; 36: 959-69.
2. Myocardial infarction redefined - A consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000; 21: 1502-13 and J Am Coll Cardiol 2000; 36: 959-69.
3. Fischer Y, Filzmaier K, Stiegler H et al. Evaluation of a new rapid bedside test for quantitative determination of B-type natriuretic peptide. Clin Chem 2001; 47: 591-4.
4. Maisel AS, Krishnaswamy P, Nowak RM et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-7.
5. Mc Donagh TA, Morrison CE, Lawrence A et al. Symptomatic and asymptomatic left ventricular systolic dysfunction in an urban population. Lancet 1997; 350: 829-33.
6. Maisel AS, Koon J, Hope H et al. A rapid bedside test for brain natriuretic peptide accurately predicts cardiac function in patients referred for echocardiography. Am Heart J 2001; 141: 374-9.
7. Cheng VL, Krishnaswamy P, Kazanegra R et al. A rapid bedside test for Brain Natriuretic Peptide predicts treatment outcomes in patients admitted with decompensated heart failure. J Am Coll Cardiol 2001; 37: 386-91.
8. Jourdain P, Funck F, Fulla Y et al. Brain natriuretic peptide et insuffisance cardiaque. Arch Mal Coeur 2001; 94: 124-9.
9. Lubien E, DeMaria A, Krishnaswamy P et al. Utility of B-natruretic peptide in detecting diastolic dysfunction: comparison with doppler velocity recordings. Circulation 2002; 10: 595-601.
10. Arakawa N, Nakamura M, Aoki H et al. Relationship between plasma level of brain natriuretic peptide and myocardial infarct size. Cardiology 1994; 85: 334-40.
11. Talwar S, Squire IB, Downie PF et al. Profile of N-terminal pro brain natriuretic peptide following acute myocardial infarction (correlation with left ventricular systolic dysfunction). Eur Heart J 2000; 21: 1514-21.
12. Nagaya N, Nishikimi T, Goto Y et al. Plasma brain natriuretic peptide is a biochemical marker for prediction of progressive ventricular remodelling after acute myocardial infarction. Am Heart J 1998; 135: 21-8.
13. Richards AM, Nicholls MG, Yandle TC et al. Plasma N-terminal pro Brain Natriuretic Peptide and adrenomedullin. New neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 1998; 97: 1921-9.
14. Omland T, Aakvaag A, Bonarjee VV et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long term survival after myocardial infarction. Circulation 1996; 93: 1963-9.
15. Kikuta K, Yasue H, Yoshimura M et al. Increased plasma levels of B-type natriuretic peptide in patients with unstable angina. Am. Heart J 1996; 132: 101-7.
16. Talwar S, Squire IB, Downie PF et al. Plasma N-terminal pro brain natriuretic peptide and cardiotrophin 1 are raised in unstable angina. Heart 2000; 84: 421-4.
17. De Lemos JA, Morrow DA, Bentley JF et al. The prognostic value of B-Type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 2001; 345: 1014-21.
18. Gianrossi R, Detrano R, Mulvihill et al. Exercise-induced ST depression in the diagnosis of coronary artery disease. A meta-analysis. Circulation 1989; 80: 87-98.
19. Miller DD, Labovitz AJ. Dipyridamole and adenosine vasodilator stress for myocardial imaging. J Am Coll Cardiol 1994; 23: 390-2.
20. Previtali M, Lanzarini L, Fetiveau R et al. Comparison of dobutamine stress echocardioaraphy, dipyridamole stress echocardiography and exercise stress testing for diagnosis of coronary artery disease. Am J Cardiol 1993; 72: 865-70.
21. Quinones MA, Verani MS, Haichin RM, Mahmarian JJ, Suarez J, Zoghbi WA. Exercise echocardiography versus 201 single photon emission computed tomography in evaluation of coronary artery disease: analysis of 292 patients. Circulation 1992; 85: 1026-31.
22. Sabatine MS, Morrow DA, De Lemos JA et al. Elevation of B-type natriuretic peptide in the setting of myocardial ischemia. Circulation 2001; 104 (Suppl. II): 11-486.